Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening | Zendy

Reinier Meester | Zendy; Chyke A. Doubeni | Zendy; Iris LansdorpVogelaar | Zendy; Christopher D. Jensen | Zendy; Miriam P. van der Meulen | Zendy; Theodore R. Levin | Zendy; Virginia P. Quinn | Zendy; Joanne E. Schottinger | Zendy; Ann G. Zauber | Zendy; Douglas A. Corley | Zendy; Marjolein van Ballegooijen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening

Author(s) -

Reinier Meester,

Chyke A. Doubeni,

Iris LansdorpVogelaar,

Christopher D. Jensen,

Miriam P. van der Meulen,

Theodore R. Levin,

Virginia P. Quinn,

Joanne E. Schottinger,

Ann G. Zauber,

Douglas A. Corley,

Marjolein van Ballegooijen

Publication year - 2015

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2015.6251

Subject(s) - medicine , colonoscopy , colorectal cancer , incidence (geometry) , adenoma , colorectal cancer screening , confidence interval , cancer , demography , physics , sociology , optics

Colonoscopy is the most commonly used colorectal cancer screening test in the United States. Its quality, as measured by adenoma detection rates (ADRs), varies widely among physicians, with unknown consequences for the cost and benefits of screening programs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research